Infectious Disease Testing Market: US, Europe, Japan: A 2011 Report by Venture Planning Group

Oct. 13, 2011 - PRLog -- Venture Planning Group (www.VPGMarketResearch.com), an international publishing and management consulting firm, is pleased to add a new report to its collection of Diagnostics Market Research and Technology Assessments publications.

"The 2011 Infectious Disease Testing Market: US, Europe, Japan" (http://www.vpgmarketresearch.com/infectious-diseases.html) is a seven-country, 1900-page report designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the infectious disease testing market during this decade.

The report provides market segmentation analysis of over 90 diseases and viruses in seven countries, reviews emerging technologies, and presents strategic profiles of leading suppliers and recent market entrants with innovative technologies and products.

Contains 1,900 pages and 820 tables

To review or order this report, visit http://www.vpgmarketresearch.com/infectious-disease-testing-market.html

Contact

Robert Fisher
Healthcare Research
robert@vpgcorp.com
+1 212 564 2838
http://www.VPGMarketResearch.com

Geographic Coverage

- France
- Germany
- Italy
- Japan
- Spain
- UK
- USA

Market Segmentation Analysis

- Sales and market shares of major suppliers of
infectious disease products, by country and individual test.

- Test and sales forecasts for over 90 infectious disease
assays by country, individual test and market segment:

- Hospitals
- Blood Banks
- Commercial/Private Laboratories
- Physician Offices/Group Practices
- Public Health Laboratories

- Review of market dynamics, trends,
structure, size, growth and major suppliers by
country.

Current and Emerging Products

- Review of major analyzers used for infectious disease
testing, including their operating
characteristics, features and selling prices.

Technology Review

- Assessment of molecular diagnostic, monoclonal antibody,
immunoassay,  and other technologies and their potential
applications for infectious disease testing.

- Extensive listings of companies developing or
marketing infectious disease products worldwide by individual test.

Competitive Assessments

- Detailed strategic assessments of major suppliers and
emerging market entrants, including their sales, product
portfolios, marketing tactics, collaborative
arrangements and new products in R&D.

Worldwide Market Overview

- Estimated universe of laboratories performing
infectious disease tests by country.

- Test volume and sales projections for major
infectious disease assays by country.

Opportunities and Strategic Recommendations

- Emerging opportunities for new instrumentation,
reagents, IT and other products with significant market
appeal during the next ten years.

- Design criteria for decentralized testing products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Methodology

The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products in the U.S., five major European countries and Japan.

In addition to primary sources of information, a comprehensive review of
the most recent technical and business publications, manufacturer product
and financial literature, as well as Venture Planning Group’s proprietary data files was conducted.

Contains 1,900 pages and 820 tables

Table of Contents

Worldwide Market and Technology Overview

A. Major Infectious Disease Tests
1. AIDS
2. Adenovirus
3. Aeromonas
4. Anthrax/Bacillus Anthracis
5. Arboviruses
6. Babesiosis
7. Bacillary Epithelioid Angiomatosis (BEA)
and Other Bartonella (Rochalimaea)
8. Blastocystis Hominis
9. Brucella
10. Campylobacter
11. Candida
12. Chagas Disease
13. Chancroid
14. Chlamydia
15. Clostridium Difficile
16. Coronaviruses
17. Coxsackieviruses
18. Creutzfeldt-Jakob’s Disease
19. Cryptosporidium Parvum
20. Cyclospora Cayetanensis
21. Cytomegalovirus
22. Ebola Virus
23. E. Coli
24. EchoVirus
25. Encephalitis
26. Enteroviruses
27. Epstein-Barr Virus
28. Giardia Lamblia
29. Gonorrhea
30. Granuloma Inguinale
31. Hantavirus
32. Helicobacter Pylori
33. Hepatitis
34. Herpes Simplex Virus
35. Human Herpes Virus-6 (HHV-6)
36. Influenza Viruses
37. Legionella
38. Lyme Disease
39. Lymphogranuloma Venereum (LGV)
40. Malaria
41. Measles (Rubeola)
42. Meningitis
43. Microsporidium
44. Mononucleosis
45. Mumps
46. Mycoplasma
47. Papillomaviruses
48. Parvovirus B19
49. Pneumonia
50. Polyomaviruses
51. Pseudomonas Aeruginosa
52. Rabies
53. Respiratory Syncytial Virus (RSV)
54. RhinoViruses
55. RotaVirus (REOVIRUS)
56. Rubella(MEASLES)
57. Salmonellosis
58. Septicemia
59. Shigellosis
60. Staphylococcus Aureus
61. Streptococci
62. Syphilis
63. Toxoplasmosis
64. Trichomonas Vaginalis
65. Tuberculosis
66. Vibrio
67. West Nile Virus
68. Yersina

B. Instrumentation Review and Market Needs
C. Emerging Diagnostic Technologies
D. Global Business Environment
E. Global Market Structure
F. Global Market Size and Growth
G. Personal Testing

Worldwide Market Overview

France

Germany

Italy

Japan

Spain

UK

USA

New Product Development Opportunities

A. Instrumentation
B. Reagent Kits and Test Systems/panels
C. Computers, Software and Automation
D. Auxiliary Products

Design Criteria for Decentralized Testing Products

Alternative Market Penetration Strategies

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized

Testing Markets

Potential Market Entry Barriers and Risks

Competitive Assessments

- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Enzo Biochem
- Fujirebio
- Gen-Probe
- Hologic
- ID Biomedical
- J&J Diagnostics
- Kreatech
- Life Technology
- Lonza
- Nanogen
- Novartis Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher
- Wallac
- Wako

Contact

Robert Fisher
Healthcare Research
robert@vpgcorp.com
+1 212 564 2838
http://www.VPGMarketResearch.com

# # #

Venture Planning Group is an international market research, publishing and management consulting firm, providing syndicated and custom services to corporate executives and key decision-makers in the Diagnostics, Pharmaceutical, Imaging, Orthopedics, Biotechnology, Chemical, Flavors & Fragrances, Food & Beverage, Electronics, and other industries.

During numerous proprietary single-client consulting assignments and over 500 multiclient studies, VPG has developed an extensive database on various industries, technologies, markets, companies, products, and executives worldwide.

VPG has served over 1,000 corporations in 70 countries, and has established a broad network of worldwide contacts with industry executives, opinion leaders, and experts from leading universities, research centers, the financial community and the government.

Specialties
Market Intelligence Surveys, Opportunity Analyses, New Technology/Product Assessments, Acquisition/Joint Venture Evaluations.